Analysis

Trisalus Life Sciences, Inc. (TLSI) Stock Analysis

Trisalus Life Sciences, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to TLSI.

websiteTLSI/analysis/TLSI

Trisalus Life Sciences, Inc.

Trisalus Life Sciences, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to TLSI.

Stock profile

Ticker

TLSI

Asset type

Stock

Market cap

$250.6M

Sector

Health Technology

Industry

Medical Specialties

Currency

USD

Ticker listings

Trisalus Life Sciences, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • TLSI primary listing

Latest Trisalus Life Sciences, Inc. news

TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery™ in Live...

WESTMINSTER, Colo., June 10, 2026--TriSalus Life Sciences, Inc. (Nasdaq: TLSI), an oncology company integrating novel delivery technology with standard-of-care therapies and an ...

TriSalus Life Sciences Reports First Quarter 2026 Results Demonstrating Commercial and Clinical Progress for Facilitating Long-Term Growth

DENVER, May 12, 2026--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the "Company"), an oncology company integrating novel delivery technology with standard of care therapies, and...

TriSalus Life Sciences Announces Launch of PREDICTT Clinical Trial Evaluating Pressure-Enabled Drug Delivery in Liver Tumors

WESTMINSTER, Colo., May 04, 2026--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the "Company"), an oncology company integrating novel delivery technology with standard of care th...

TriSalus Life Sciences to Host First Quarter 2026 Financial Results Conference Call

WESTMINSTER, Colo., April 28, 2026--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the "Company"), an oncology company integrating novel delivery technology with standard of care ...

TriSalus Life Sciences to Present New Data at the 2026 Society of Interventional Radiology Annual Scientific Meeting

WESTMINSTER, Colo., April 09, 2026--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the "Company"), an oncology company integrating novel delivery technology with standard of care ...

Research sections

Valuation

Review valuation context for Trisalus Life Sciences, Inc..

Future growth

Review future growth context for Trisalus Life Sciences, Inc..

Past performance

Review past performance context for Trisalus Life Sciences, Inc..

Financial health

Review financial health context for Trisalus Life Sciences, Inc..

Dividend

Review dividend context for Trisalus Life Sciences, Inc..

Management

Review management context for Trisalus Life Sciences, Inc..

Ownership

Review ownership context for Trisalus Life Sciences, Inc..

Other information

Review other information context for Trisalus Life Sciences, Inc..

Community

Review community context for Trisalus Life Sciences, Inc..